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Background. We aimed to evaluate the efficacy of various diagnostic tools such as computerized tomography (CT), small bowel
follow-through (SBFT), and capsule endoscopy (CE) in diagnosing small bowel tumors (SBTs). Additionally, we aimed to evaluate
the clinical features of SBTs missed by CE.Methods. We retrospectively studied 79 patients with histologically proven SBT. Clinical
data were analyzed with particular attention to the efficacy of CT, SBFT, and CE in detecting SBT preoperatively. We also analyzed
the clinical features of SBTs missed by CE. Results. The most common symptoms of SBT were bleeding (43%) and abdominal pain
(13.9%). Diagnostic yields were as follows: CT detected 55.8% of proven SBTs; SBFT, 46.1%; and CE, 83.3%. The sensitivity for
detecting SBTs was 40.4% for CT, 43.9% for SBFT, and 79.6% for CE. Two patients with nondiagnostic but suspicious findings
on CE and seven patients with negative findings on CE were eventually found to have SBT. These nine patients were eventually
diagnosed with gastrointestinal stromal tumor (4), small polyps (3), inflammatory fibroid polyp (1), and adenocarcinoma (1).These
tumors were located in the proximal jejunum (5), middle jejunum (1), distal jejunum (1), and proximal ileum (1). Conclusion. CE is
more efficacious than CT or SBFT for detecting SBTs. However, significant tumors may go undetected with CE, particularly when
located in the proximal jejunum.
1. Introduction
The small intestine represents 75% of the length and 90%
of the absorptive surface area of the gastrointestinal system.
However, small bowel tumors (SBTs) are rare, representing
only 3–6% of gastrointestinal (GI) tract tumors and only 1–
3% of all malignant GI tumors [1]. The diagnosis of SBTs is
difficult and is frequently delayed. Conventional diagnostic
modalities are inaccurate and inconclusive [2] and frequently
fail to detect early or locally advanced stages because of
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the inaccessibility of the small bowel. Indirect evaluation is
possible with small bowel follow-through (SBFT) or com-
puted tomography (CT), but disadvantages include patient
discomfort, high radiation dose, and, most importantly, poor
sensitivity in detecting SBTs [3, 4].
Capsule endoscopy (CE) allows painless endoscopic
imaging of the entire small bowel. CE has rapidly gained
acceptance as a standard method for small bowel evaluation
even though it is contraindicated in patients with suspected
or documented intestinal obstruction and does not allow
therapeutic intervention [5, 6]. In large cohort undergoing
CE, the prevalence of SBT ranges from 2 to 9%, higher
than previously reported [7–14]. CE may provide the earlier
diagnosis and treatment of SBTs compared to compara-
tive methods [8, 15]. However, some studies revealed that
CE can miss some significant tumor in the small bowel
[16–18].
This study aimed to investigate the characteristics of
SBTs confirmed by pathology, to compare diagnostic yields
among various diagnostic methods, and to identify the
characteristics of SBTs missed by CE.
2. Materials and Methods
The records of 79 patients with histology proven SBTs by
surgery (43 patients) or double balloon enteroscopy (DBE,
65 patients) from March 2004 to December 2012 were
retrospectively studied. Patients had been treated at 7medical
referral centers in Korea and had undergone surgery or DBE
for SBT removal. We reviewed the clinical characteristics
of SBTs; the diagnostic yields of SBFT, CT, and CE; and
the characteristics of SBTs not detected by CE. Of these 79
patients, 39 (49.3%) underwent SBFT, 68 (86.1%) underwent
CT, and 54 (68.3%) underwent CE before SBTs were con-
firmed. Findings of these diagnostic studies were interpreted
by experienced endoscopists and radiologists, and the results
were classified into three categories: definite, suspicious, or
negative.When SBFT, CT, or CE revealed findings considered
confirmatory of a diagnosis of SBT, the results were classified
in the “definite SBT” category.When findings were suggestive
but not confirmatory of SBT, the results were classified
as “suspicious SBT.” When no evidence of neoplasia was
found, the results were classified as “negative.” Locations
of SBTs were classified as duodenum, jejunum (proximal,
mid, or distal), and ileum (proximal, mid, or distal). In
patients operated on, the locations of SBTs were classified
according to operative findings. In patients nonoperated on,
we approximately estimated the locations of SBTs with the
depth of insertion of enteroscope, the size of small intestinal
lumen, and the shape of villi and folds.
2.1. Capsule Endoscopy. The PillCam SB video (SB1 and SB2,
Given Imaging, Yokneam, Israel) andMiroCam (IntroMedic,
Seoul, South Korea) were used for CE. Polyethylene glycol
solution (2–4 L) was administered before the examination
for cleansing and enhancement of visual clarity. Video
findings were interpreted by experienced gastrointestinal
endoscopists at each center.
Table 1: Clinical characteristics of patients with small bowel tumors
and characteristics of small bowel tumors.
Clinical characteristics 𝑁 (%)
M : F 50 : 29
Age (years, mean ± SD) 47.2 ± 20.2
Mean duration of symptoms (days ± SD) 168.9 ± 966.6
Smoking (current) 13 (16.4%)
Alcohol (current) 17 (21.5%)
Comorbidity
Hypertension 7 (8.9%)
Diabetes mellitus 2 (2.5%)
Liver cirrhosis 1 (1.3%)
Others 14 (17.8%)
Hb (g/dL, mean ± SD) 10.1 ± 2.9
Anemia 45 (57%)
Protein (g/dL, mean ± SD) 6.1 ± 0.9
Albumin (g/dL, mean ± SD) 3.7 ± 0.6
Characteristics of small bowel tumors
Single tumor 54 (68.3%)
Size of tumor (cm, mean ± SD) 3.5 ± 2.6
Extents
Localized 68 (86.1%)
Locally advanced 6 (7.6%)
Metastasis 5 (6.3%)
2.2. Double Balloon Enteroscopy. DBE was performed using
EN-450P5/20 or EN-450T5 (Fujinon Inc., Saitama, Japan)
under conscious sedation. All procedures were carried out
by experienced endoscopists.The technique for insertion has
been previously described [19]. Enteroscopic exploration was
discontinued when the targeted lesion was reached. Total
enteroscopy was confirmed by reaching the cecum, or by
reaching an India ink stain previously made through the
other approach. Biopsy, polypectomy, or endoscopic mucosal
resection specimens obtained by DBE were reviewed by
experienced pathologists. The protocol was approved by the
Institutional Review Board at each institute.
2.3. Statistical Analysis. SPSS 11.5 (SPSS Inc., Chicago, IL)
was used for all statistics. Continuous variables are presented
as means ± standard deviations and were analyzed using
ANOVA. The comparisons of clinical factors affecting diag-
nostic yields of SBTs by CT, SBFT, and CE were assessed by
using chi-square test and Fisher exact test. The proportions
of patients with positive findings at two examinations were
compared, and a significant difference between the tests was
calculated by using the exact McNemar test. A 𝑃 value < 0.05
was considered statistically significant.
3. Results
3.1. Clinicopathologic Characteristics of SBTs. The clinical
characteristics of patients are presented in Table 1. The inci-
dence of SBTs was higher in men (63.3%) than in women














Figure 1: Various indications of diagnostic tests for small bowel
tumors.
(36.7%). Forty-five (57%) of 79 patients had anemia, and
the mean hemoglobin level was 10.1 ± 2.9 g/dL. The mean
size of SBTs was 3.5 ± 2.6 cm, and 54 patients (68.3%) had
a single lesion. SBTs were localized in 68 patients (86.1%)
and locally advanced in 6 patients (7.6%) and metastatic
disease was present in 5 patients (6.3%). The most frequent
symptom was overt GI bleeding (36.7%) and abdominal
pain (13.9%) (Figure 1). Of 43 patients who were treated
by surgery, 29 patients underwent DBE and surgery and 14
patients underwent surgery without DBE.The size of tumors
in the patientswithDBE and surgerywas significantly smaller
than the patients diagnosed by surgery without DBE (3.31 ±
2.33 cm versus 5.88 ± 2.93 cm, 𝑃 = 0.031).
3.2. Locations of SBTs according to Diagnosis. The SBTs were
benign in 63 patients (79.7%) and malignant in 16 patients
(20.3%). Benign tumors were leiomyoma (24/52, 46.2%),
hamartoma (17/52, 32.7%), benign polyps (7/52, 13.5%),
lipoma (3/52, 5.8%), and hemangioma (1/51, 2.9%).Malignant
tumors were adenocarcinoma (7/16, 43.8%), gastrointestinal
stromal tumor (GIST) (5/16, 31.3%), lymphoma (3/16, 18.8%),
and carcinoid tumor (1/16, 6.3%). Both benign andmalignant
tumors occurred most frequently in the proximal jejunum
(34/79, 43.0%) followed by the distal ileum (9/79, 11.4%),
duodenum (8/79, 10.1%), middle jejunum (6/79, 7.6%), distal
jejunum (5/79, 6.3%), proximal ileum (4/79, 5.1%), and
middle ileum (3/79, 3.8%).
3.3. Diagnostic Yields of SBFT, CT, and CE for SBTs. The
diagnostic yields for definitive SBTs were 55.8% (38/68) in
CT, 46.1% (18/39) in SBFT, and 83.3% (45/54) in CE (Table 2).
Using DBE as a reference in the 95% confidence interval (CI),
the sensitivity of each diagnostic method was 40.4% (95%
CI, 27.01–54.90%) in CT, 43.9% (95% CI, 28.47–60.25%) in
SBFT, and 79.6% (95%CI, 65.66–89.76%) in CE. A significant
difference was found between diagnostic yields of CE and
Table 2: Comparison of diagnostic yields of CE and other radiologic
studies.
CT SBFT CE DBE
Definitive 38 (55.8%) 18 (46.1%) 45 (83.3%) 61 (93.8%)
Suspicious 20 (29.4%) 9 (23.1%) 2 (3.7%)
Negative 10 (14.7%) 12 (30.7%) 7 (12.9%) 4 (6.2%)
Total 68 39 54 65
CE: capsule endoscopy; SBFT: small bowel follow-through; CT: computed
tomography; DBE: double balloon enteroscopy.
Table 3: Comparison of diagnostic yields of capsule endoscopy and
other radiologic studies.
Difference (%) 95% CI (%) 𝑃 value
CE versus SBFT 36.36 9.36–50.64 0.0075
CE versus CT 33.33 12.75–43.82 0.0015
CE: capsule endoscopy; SBFT: small bowel follow-through; CT: computed
tomography.
Table 4: Clinical factors affecting diagnostic yields of eachmodality.
Clinical factors CT SBFT CE
Anemia
Presence 52.5% 48% 75%
Absence 16.2% 30% 85.7%
𝑃 value 0.019 0.333 0.638
Size of tumor
<10mm 30% 14.2% 77.7%
>10mm 37.5% 46.1% 60%
𝑃 value 0.900 0.043 0.624
Main symptoms
Bleeding 57.6% 50% 66.6%
Nonbleeding 42.4% 50% 68.9%
𝑃 value 0.021 0.458 0.615
Location 𝑃 value 0.054 0.546 0.485
CE: capsule endoscopy; SBFT: small bowel follow-through; CT: computed
tomography.
SBFT (36.36%; 95% CI, 9.36–50.64%; 𝑃 = 0.0075) and
between those of CE and CT (33.33%, 95% CI, 12.75–43.82%;
𝑃 = 0.0015) (Table 3).The clinical factors affecting diagnostic
yields were the presence of anemia (𝑃 = 0.019) and bleeding
(𝑃 = 0.043) for CT and tumor size >10mm (𝑃 = 0.021) for
SBFT (Table 4).There were no statistically significant clinical
factors affecting diagnostic yields of CE.
There were 32 patients who had all three modalities (CT,
SBFT, and CE). We compared the sensitivities of these three
modalities in 32 patients. It showed that the sensitivity of CE
for SBTs is significantly higher than SBFT or CT (Table 5).
3.4. Characteristics of SBTs Missed by CE. In nine (16.7%)
of 54 patients, SBTs were not detected by CE but were
eventually diagnosed by DBE. Seven patients had negative
findings and twopatients had suspicious findings onCE. SBTs
>10mm were identified in six patients (66.7%). Most of the
missed SBTs were located in the proximal jejunum (5, 55.6%),
followed by the proximal ileum (2, 22.2%), middle jejunum
(1, 11.1%), and distal jejunum (1, 11.1%). The final diagnoses
in these nine patients were GIST (4, 44.4%), small polyps (3,
4 Gastroenterology Research and Practice
Table 5: Comparisons of sensitivities of three modalities for small
bowel tumors.
CE Total 𝑃 value
Definitive Suspicious Negative
CT 0.005
Definitive 10 1 1 12
Suspicious 13 0 5 18
Negative 1 1 0 2
Total 24 2 6 32
SBFT 0.046
Definitive 10 0 3 13
Suspicious 5 1 1 7
Negative 9 1 2 12
Total 24 2 6 32
CE: capsule endoscopy; SBFT: small bowel follow-through; CT: computed
tomography.
33.3%), adenocarcinoma (1, 11.1%), and inflammatory fibroid
polyp (1, 11.1%).
4. Discussion
In this study, we demonstrated that the most common
SBT was leiomyoma for benign tumor and adenocarcinoma
for malignancy, and the most common location of SBTs
was proximal jejunum in Korea. The diagnostic yield and
sensitivity of CE was higher than SBFT and CT scan. We also
found that the SBTs missed by CE were 16.7%, missed SBTs
were mostly located in proximal jejunum, and GIST was the
most common histologic type of missed SBTs.
Primary small bowel neoplasms are rare accounting for
only 3% of all gastrointestinal tract neoplasia in the United
States [20]. In Korea, the 2008 annual report of cancer
statistics showed that small intestinal cancer accounted for
0.98% of all GI malignancies [21]. However, several studies
have reported an increasing incidence of SBTs [22, 23]. SBTs
are often diagnosed too late for successful treatment because
clinical manifestations of SBTs are usually nonspecific and
conventional radiologic tests have some limitations to detect
small sized SBTs.
The study from the United States showed that carcinoid
tumor is themost common SBTs rather than adenocarcinoma
[24]. Cangemi et al. reported that the most common SBT was
carcinoid tumor (19.4%) followed by GIST and lymphoma
[25]. They also reported that hamartoma (10.4%) was the
most common benign tumor, followed by inflammatory
polyps and adenoma. In Japan, lymphoma (21.5%) and
GIST (18.8%) were the most common tumors, and carcinoid
tumors were rare (2.8%) [26]. In recent Korean studies,
carcinoid tumor is rare in the small intestine [27, 28]. This
difference is presumed to be a result of genetic and ethnic
factors. Primary adenocarcinoma is the most common SBT
detected by DBE in another Japanese study [29]. In a Korean
study of 112 patientswith SBTs, themost commonmalignancy
was GIST/leiomyoma and the most common benign polyp
was hamartoma [29]. In our study, leiomyoma andGISTwere
categorized separately, and the most common benign SBT
was leiomyoma. Adenocarcinoma was the most common
malignancy in our study. Further studies are needed to
accurately determine the frequency of SBTs in Korea.
The most common location of SBTs is the ileum in a
previous study of the United States [25]. Our study found
that the distribution of SBTs is similar to that of a previous
Korean study, which reported that SBTs were most frequently
located in the jejunum (61.7%), followed by ileum (34.9%)
and duodenum (16.1%) [29].
Diagnostic radiology studies such as SBFT, enteroclysis,
and CTwere traditionally used to diagnose SBTs. SBFT is rel-
atively easy to perform and is tolerable for patients. However,
the sensitivity of SBFT is 30–44%. Enteroclysis has a better
diagnostic yield, but it requires a highly skilled radiologist
and may cause significant discomfort for patients. Despite
the advances in CT technology, conventional CT scans still
detect only large tumors greater than 10mm in diameter. In
comparison, the diagnostic yield of CE was superior to those
of CT and SBFT [30, 31]. The diagnostic impact of CE for
SBTs was reported as 52.6% [22]. CE also allows endoscopic
imaging of the entire small bowel without discomfort or
exposure to radiation. However, CE is contraindicated for
patients with suspected or documented intestinal obstruction
and presents no opportunity for histological confirmation or
therapeutic intervention. Our results demonstrated that CE
has a higher diagnostic yield and sensitivity than those of
other radiologic modalities.
We demonstrated that the miss rate of CE for SBTs
was 16.5%. We also found that missed tumors were most
commonly located in the proximal jejunum (55.6%). Ameta-
analysis including 24 studies and over 500 patients found
that the overall miss rate of CE for small bowel mass lesions
was 18.6% [32]. Ross et al. reported that CE identified the
mass lesion in only 5 (33%) of 15 patients with SBTs [17].
There are several possible explanations for nondetection of
SBTs by CE. SBTs are usually single, whereas most patients
with angiodysplasia or ulcers have multiple lesions. SBTs
are usually located in the proximal small bowel and may
be missed because of tumbling or excessive capsule transfer
velocity due to excessive bowel peristalsis. Therefore, the
detection of SBTs by CE remains a challenge despite CE being
a major advance in small bowel evaluation.
Our study is limited by its retrospective design. Fur-
thermore, because our study included only patients with
proven SBTs, the specificity of each diagnostic method could
not be analyzed. There are limitations to measure accurate
sensitivity or miss rate of CE because the patients with
negative CE results were more likely not to undergo DBE or
surgery.
Taken together, we concluded that CE shows higher
diagnostic yield and sensitivity for the diagnosis of SBTs
compared with other radiologic tests. However, CE can
miss some significant tumors, particularly those located in
the proximal jejunum. Further endoscopic investigation by
deep enteroscopy should be considered for patients with
nonspecific findings on CE but high clinical suspicion for
SBT.
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